Win Back Control: a gambling self-help tool

Not Applicable

Completed

Conditions: Problematic gambling
Mental and Behavioural Disorders

Registration Number: ISRCTN16339434

Lead Sponsor: Research Institute for Public Health and Addiction (ISGF)

Brief Summary: 2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31818841/ protocol (added 05/11/2020) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37659086/ (added 04/06/2024)

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 360

Inclusion Criteria

1. Gambling activity at least once a week 30 days prior to study entry
2. At least 18 years old
3. Internet access
4. Proficiency in German or French

Exclusion Criteria

1. Self-reported engagement in other psychosocial treatments for problem gambling
2. Elevated suicidality (scoring greater than minimal risk” on a screener
3. Past-90 day psychosis or mania
4. Presence of a severe substance use disorder (SUD)

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 18/03/2019:<br>Primary outcome variable will the number of days played over last 30 days assessed through self-report questionnaire form at baseline, after 8 weeks and at 24 weeks follow-up.<br><br>Previous primary outcome measure:<br>Primary outcome variable will be the time spent gambling, the number of days per week of play and the amount of money lost assessed through self-report questionnaire form at baseline, after 8 weeks and at 24 weeks follow-up.

Secondary Outcome Measures

Name	Time	Method
1. Problem gambling severity measured using the PGSI at initial assessment, after 8 weeks and at 24 weeks follow-up.<br>2. Symptoms of gambling disorder measured using the G-SAS at initial assessment, after 8 weeks and at 24 weeks follow-up.<br>3. Use of alcohol and tobacco measured using timeline followback forms at initial assessment, after 8 weeks and at 24 weeks follow-up.<br>4. Depression measured using PHQ-9 at initial assessment and at 24 weeks follow-up.<br>5. Anxiety measured using GAD-7 at initial assessment and at 24 weeks follow-up.<br>6. Attention deficit symptoms measured using ASRS-V1.1 at initial assessment and at 24 weeks follow-up.<br>7. PTSD measured using the Short Screening Scale for DSM-IV Posttraumatic Stress Disorder at initial assessment and at 24 weeks follow-up.<br>8. Client satisfaction measured using the CSQ-I measured after 8 weeks.<br>9. Treatment retention measured using consumption diary continuously.